On 11 June, the BIA and the Medicines and Healthcare Products Regulatory Agency (MHRA) will be joining forces to hold our established conference for the fifth year. As the event draws closer, we’ve highlighted what you can expect from the day below.
The fifth joint UK BioIndustry Association (BIA) and Medicines and Healthcare Products Regulatory Agency (MHRA) conference presents the opportunity to network with regulatory experts, while showcasing the collaborative approach between stakeholders to support innovation and facilitate clinical development and timely access to new treatments and vaccines.
This year the keynote presentation will be delivered by Professor Sir Michael Rawlins, newly appointed chair of the MHRA, who will discuss patient access to innovative therapies and technologies. With senior experts and leading speakers from the MHRA and National Institute for Biological Standards and Control (NIBSC), the life science industry, the Wellcome Trust, the Jenner Institute and patient organisations, the conference is the ideal place to hear the very latest thinking on topics including:
- Patient involvement. During this session an insight into patient involvement in regulatory decision-making and drug development will be provided from patient, industry and regulatory perspectives. Guaranteed to spark discussion, the session will be followed by a panel discussion and Q&A.
- NIBSC/ MHRA post-merger. Following their merger, both organisations are keen to showcase their collaborative approach in the research and development of medicines. Speakers from the NIBSC and MHRA will engage the audience in areas such as progress with advanced therapy medicinal products and recent regulatory developments in this area, and the role of NIBSC in the standardisation of biosimilars and development of assays for immunogenicity.
- Accelerated regulatory approvals and processes. Taking the response against the Ebola virus disease as a case study, the afternoon session will focus on stakeholder collaboration to address public health emergency and find innovative solutions to facilitate clinical development and timely access to new vaccines and treatments. Following a key note presentation, ‘Ebola – Where are we today and where are we going?’, academic, industry and regulatory presentations will cover activities from bench science to clinical research. A panel discussion and Q&A will round off the afternoon, covering lessons learnt and how they might apply to other therapeutic areas.
If the above details have peaked your interest, you can find out more about the event – including full programme details and confirmed speakers – here.
The fifth joint BIA and MHRA conference, Pathway of Innovation from Research to Patients, will take place on Thursday 11th June at the Wellcome Trust, and is open to all members and non members. To register please click here.